11-17527316-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_153676.4(USH1C):​c.403G>A​(p.Val135Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00247 in 1,612,278 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. V135V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0023 ( 3 hom., cov: 30)
Exomes 𝑓: 0.0025 ( 5 hom. )

Consequence

USH1C
NM_153676.4 missense

Scores

1
7
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:9

Conservation

PhyloP100: 7.57

Publications

7 publications found
Variant links:
Genes affected
USH1C (HGNC:12597): (USH1 protein network component harmonin) This gene encodes a scaffold protein that functions in the assembly of Usher protein complexes. The protein contains PDZ domains, a coiled-coil region with a bipartite nuclear localization signal and a PEST degradation sequence. Defects in this gene are the cause of Usher syndrome type 1C and non-syndromic sensorineural deafness autosomal recessive type 18. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
USH1C Gene-Disease associations (from GenCC):
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 1C
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, PanelApp Australia
  • autosomal recessive nonsyndromic hearing loss 18A
    Inheritance: AR, Unknown Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011645734).
BP6
Variant 11-17527316-C-T is Benign according to our data. Variant chr11-17527316-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 48015.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00232 (352/151962) while in subpopulation AMR AF = 0.00432 (66/15278). AF 95% confidence interval is 0.00348. There are 3 homozygotes in GnomAd4. There are 163 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR,Unknown gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_153676.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
USH1C
NM_153676.4
MANE Select
c.403G>Ap.Val135Ile
missense
Exon 5 of 27NP_710142.1
USH1C
NM_005709.4
MANE Plus Clinical
c.403G>Ap.Val135Ile
missense
Exon 5 of 21NP_005700.2
USH1C
NM_001440679.1
c.436G>Ap.Val146Ile
missense
Exon 5 of 22NP_001427608.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
USH1C
ENST00000005226.12
TSL:5 MANE Select
c.403G>Ap.Val135Ile
missense
Exon 5 of 27ENSP00000005226.7
USH1C
ENST00000318024.9
TSL:1 MANE Plus Clinical
c.403G>Ap.Val135Ile
missense
Exon 5 of 21ENSP00000317018.4
USH1C
ENST00000527020.5
TSL:1
c.403G>Ap.Val135Ile
missense
Exon 5 of 20ENSP00000436934.1

Frequencies

GnomAD3 genomes
AF:
0.00232
AC:
352
AN:
151844
Hom.:
3
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000508
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00433
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.000390
Gnomad SAS
AF:
0.000209
Gnomad FIN
AF:
0.000378
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00353
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00227
AC:
568
AN:
250276
AF XY:
0.00245
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.00275
Gnomad ASJ exome
AF:
0.000993
Gnomad EAS exome
AF:
0.000652
Gnomad FIN exome
AF:
0.00141
Gnomad NFE exome
AF:
0.00339
Gnomad OTH exome
AF:
0.00294
GnomAD4 exome
AF:
0.00249
AC:
3634
AN:
1460316
Hom.:
5
Cov.:
33
AF XY:
0.00251
AC XY:
1821
AN XY:
726534
show subpopulations
African (AFR)
AF:
0.000299
AC:
10
AN:
33480
American (AMR)
AF:
0.00280
AC:
125
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00172
AC:
45
AN:
26134
East Asian (EAS)
AF:
0.000277
AC:
11
AN:
39698
South Asian (SAS)
AF:
0.000603
AC:
52
AN:
86252
European-Finnish (FIN)
AF:
0.00175
AC:
91
AN:
51994
Middle Eastern (MID)
AF:
0.00174
AC:
10
AN:
5752
European-Non Finnish (NFE)
AF:
0.00283
AC:
3147
AN:
1111904
Other (OTH)
AF:
0.00237
AC:
143
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
179
358
536
715
894
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00232
AC:
352
AN:
151962
Hom.:
3
Cov.:
30
AF XY:
0.00220
AC XY:
163
AN XY:
74246
show subpopulations
African (AFR)
AF:
0.000506
AC:
21
AN:
41462
American (AMR)
AF:
0.00432
AC:
66
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3470
East Asian (EAS)
AF:
0.000391
AC:
2
AN:
5120
South Asian (SAS)
AF:
0.000209
AC:
1
AN:
4780
European-Finnish (FIN)
AF:
0.000378
AC:
4
AN:
10588
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00353
AC:
240
AN:
67946
Other (OTH)
AF:
0.00379
AC:
8
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
15
30
46
61
76
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00279
Hom.:
3
Bravo
AF:
0.00234
TwinsUK
AF:
0.00297
AC:
11
ALSPAC
AF:
0.00363
AC:
14
ESP6500AA
AF:
0.000909
AC:
4
ESP6500EA
AF:
0.00303
AC:
26
ExAC
AF:
0.00227
AC:
275
EpiCase
AF:
0.00294
EpiControl
AF:
0.00450

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:9
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Usher syndrome type 1C Uncertain:1Benign:3
Apr 11, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

May 18, 2021
Pars Genome Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.

Jul 22, 2021
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

USH1C: BS2

Sep 18, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Autosomal recessive nonsyndromic hearing loss 18A Uncertain:1Benign:1
Dec 26, 2024
Laboratory of Prof. Karen Avraham, Tel Aviv University
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

The USH1C c.403G>A:p.(Val135Ile) heterozygous, possibly deleterious variant was detected in an individual with sloping normal-to-moderate HL. In the same individual, two additional variants, both of them founders, have been detected in two other USH genes; one a known pathogenic variant in PCDH15, c.733C>T:p.(Arg245*), and the other, a VUS in ADGRV1, c.8308T>C:p.(Phe2770Leu), suggesting digenic or trigenic inheritance.

Jul 22, 2021
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:2
Sep 13, 2016
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 18, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Val135Ile in exon 5 of USH1C: This variant is not expected to have clinical si gnificance because it has been identified in 0.3% (227/66532) of European chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs145013633).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.33
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Benign
0.074
T
Eigen
Uncertain
0.43
Eigen_PC
Uncertain
0.51
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.89
D
M_CAP
Benign
0.046
D
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.87
L
PhyloP100
7.6
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
0.0
N
REVEL
Uncertain
0.30
Sift
Benign
0.18
T
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.81
MVP
0.37
MPC
0.36
ClinPred
0.028
T
GERP RS
5.1
Varity_R
0.29
gMVP
0.44
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145013633; hg19: chr11-17548863; COSMIC: COSV109404622; API